1. Home
  2. PRPO vs TELA Comparison

PRPO vs TELA Comparison

Compare PRPO & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$24.04

Market Cap

44.4M

Sector

Industrials

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.86

Market Cap

41.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRPO
TELA
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.4M
41.3M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
PRPO
TELA
Price
$24.04
$0.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.00
AVG Volume (30 Days)
18.6K
127.3K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
92.15
37.59
EPS
N/A
N/A
Revenue
$24,049,000.00
$80,275,000.00
Revenue This Year
N/A
$10.23
Revenue Next Year
N/A
$14.26
P/E Ratio
N/A
N/A
Revenue Growth
29.77
15.84
52 Week Low
$9.67
$0.50
52 Week High
$33.63
$2.19

Technical Indicators

Market Signals
Indicator
PRPO
TELA
Relative Strength Index (RSI) 39.53 51.16
Support Level $22.96 $0.67
Resistance Level $26.16 $0.91
Average True Range (ATR) 1.84 0.11
MACD -0.15 -0.01
Stochastic Oscillator 30.02 45.65

Price Performance

Historical Comparison
PRPO
TELA

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: